Brief: Amphastar Announces FDA Approval for Teriparatide Injection
15/12/2025 11:22
Dec 15 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O: AMPHASTAR PHARMACEUTICALS INC: FDA APPROVAL FOR TERIPARATIDE INJECTION AMPHASTAR PHARMACEUTICALS: FDA DETERMINED THAT CO'S TERIPARATIDE IS BIOEQUIVALENT & THERAPEUTICALLY EQUIVALENT TO ELI LILLY'S FORTEO AMPHASTAR PHARMACEUTICALS INC: PLANS TO LAUNCH ITS TERIPARATIDE INJECTION BY END OF YEAR Further company coverage: AMPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing